What's new

Human medicines European public assessment report (EPAR): Dazluma, troriluzole, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Dazluma, troriluzole, Status: Application withdrawn

Apr 25, 2025 - 15:03
 0
Human medicines European public assessment report (EPAR): Dazluma, troriluzole, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Dazluma, troriluzole, Status: Application withdrawn
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Oczyesa, octreotide, S...

Next Article

Summary of opinion: Zoonotic Influenza Vaccine Seqirus, 25/04/2025 Positive

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Enspryng, satralizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders;Neurology, PIP number: P/0069/2024

Opinion/decision on a Paediatric investigation plan (PI...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Duvyzat, givinostat, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Movymia, teriparatide, Date of authorisation: 11/01/2017, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0